Li Shen, Jiang Song, Zhang Qingyan, Jin Bo, Lv Daoyuan, Li Wenju, Zhao Min, Jiang Chunming, Dai Chunsun, Liu Zhihong
National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University Medical School, Nanjing, China.
Department of Nephrology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Front Cell Dev Biol. 2021 Nov 5;9:733831. doi: 10.3389/fcell.2021.733831. eCollection 2021.
Tubular cell senescence is a common biologic process and contributes to the progression of chronic kidney disease (CKD); however, the molecular mechanisms regulating tubular cell senescence are poorly understood. Here, we report that integrin β3 (ITGB3) expression was increased in tubular cells and positively correlated with fibrosis degree in CKD patients. ITGB3 overexpression could induce p53 pathway activation and the secretion of TGF-β, which, in turn, resulted in senescent and profibrotic phenotype change in cultured tubular cells. Moreover, according to the CMAP database, we identified isoliquiritigenin (ISL) as an agent to inhibit ITGB3. ISL treatment could suppress Itgb3 expression, attenuate cellular senescence, and prevent renal fibrosis in mice. These results reveal a crucial role for integrin signaling in cellular senescence, potentially identifying a new therapeutic direction for kidney fibrosis.
肾小管细胞衰老为常见生物学过程,且会促使慢性肾脏病(CKD)进展;然而,调控肾小管细胞衰老的分子机制仍鲜为人知。在此,我们报告称,整合素β3(ITGB3)在肾小管细胞中的表达增加,且与CKD患者的纤维化程度呈正相关。ITGB3过表达可诱导p53通路激活及TGF-β分泌,进而导致培养的肾小管细胞出现衰老和促纤维化表型改变。此外,根据CMAP数据库,我们确定异甘草素(ISL)为抑制ITGB3的药物。ISL治疗可抑制Itgb3表达,减轻细胞衰老,并预防小鼠肾纤维化。这些结果揭示了整合素信号在细胞衰老中的关键作用,可能为肾纤维化确定新的治疗方向。